Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment for Reading and Writing Deficits Following Acquired Brain Injury

NCT03662243 is registered in ClinicalTrials.gov with Quality Living, Inc. as lead sponsor.

NCT NCT03662243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03662243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment for Reading and Writing Deficits Following Acquired Brain Injury
Lead sponsor
Quality Living, Inc.
Phase
Observational
Overall status
Completed
Start date
August 30, 2018
Completion date
September 15, 2020
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired brain injury, agraphia, alexia